Olivia’s cancer center receives $45 million for completion

Victorian Premier Ted Baillieu has finally sanctioned funds to complete the Olivia Newton-John Cancer and Wellness Centre. The Premier has committed almost $45 million to fit out the Austin Hospital project that was incomplete.

Less than a year since she serenaded then-Premier John Brumby for his commitment, Ms Newton-John said she was now looking forward to working with Mr Baillieu to complete the hospital. “I'm just absolutely thrilled that Mr Baillieu and (Health Minister David) Davis have come through - I believed that they would, but I didn't know it would happen so fast…I couldn't believe they would leave us half-finished like that. I had faith - it was a little scary at times. It's not about the politics, it's about the cancer centre and it being funded… Cancer affects everybody,” Ms Newton-John said. She herself is a breast cancer survivor and has worked for eight years to make her dream centre a reality.

The Coalition had refused to guarantee the project since Labor's promise to back the final stage of the hospital evaporated with its election loss. Mr Baillieu, announcing the funding, said he was being forced to fill in a budget “black hole” because Labor made its commitment without allocating any money for it. “They started a hospital without a funding commitment,” he said. But Opposition Leader Daniel Andrews said Labor's poll promise to fund the third stage was fully funded and costed in documents signed off by the state treasury. Treasurer Kim Wells did not detail where the government was able to find the $45 million to fund the centre's fitout, saying it was part of a continuing budget process.

Austin chief Dr Brendan Murphy said outpatients would be treated next year and wards open in 2013. About 2000 Victorians are expected to receive treatment at the centre. “We are going to provide Victorians with a state of the art, world-class facility that will help and heal the lives of so many,” Ms Newton-John said.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Olivia’s cancer center receives $45 million for completion. News-Medical. Retrieved on November 15, 2024 from https://www.news-medical.net/news/20110405/Olivias-cancer-center-receives-2445-million-for-completion.aspx.

  • MLA

    Mandal, Ananya. "Olivia’s cancer center receives $45 million for completion". News-Medical. 15 November 2024. <https://www.news-medical.net/news/20110405/Olivias-cancer-center-receives-2445-million-for-completion.aspx>.

  • Chicago

    Mandal, Ananya. "Olivia’s cancer center receives $45 million for completion". News-Medical. https://www.news-medical.net/news/20110405/Olivias-cancer-center-receives-2445-million-for-completion.aspx. (accessed November 15, 2024).

  • Harvard

    Mandal, Ananya. 2020. Olivia’s cancer center receives $45 million for completion. News-Medical, viewed 15 November 2024, https://www.news-medical.net/news/20110405/Olivias-cancer-center-receives-2445-million-for-completion.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel bladder cancer treatment gains MHRA approval in the UK